4. Robbins & Myers ( RBN) is a supplier of equipment and systems for critical applications in the global energy, industrial, chemical and pharmaceutical markets. The company will announce its first-quarter fiscal 2012 results on Jan. 6. Net income for the quarter is estimated at $31.46 million, or 68 cents per share, compared to $14.70 million, or 44 cents per share, in the same quarter prior fiscal, according to analysts polled by Bloomberg. Sales are seen at $242.13 million, an increase of 48% from $163.95 million recorded in the first quarter of fiscal 2011. Operating profit for the period is seen growing 96% to $47.46 million. Return on equity during the quarter rose to 11% from 8.56% earlier. EBITDA is expected to rise 99% to $55.80 from $28.09 in the previous year's quarter. Currently, the company has a dividend yield of 0.4%. Of the 11 analysts covering the stock, 73% recommend a buy and 18% rate a hold. Analysts polled by Bloomberg expect the stock to gain an average 12.9% to $54.40 from current levels over the next 12 months.